The Code of Federal Regulations of the United States of AmericaU.S. Government Printing Office, 1993 The Code of Federal Regulations is the codification of the general and permanent rules published in the Federal Register by the executive departments and agencies of the Federal Government. |
No grāmatas satura
1.–5. rezultāts no 31.
5. lappuse
... active principle of pan- creas which affects the metabolism of carbohydrate in the animal body and which is of value in the treatment of diabetes mellitus . ( b ) The following substances , when they are intended for use in the manu ...
... active principle of pan- creas which affects the metabolism of carbohydrate in the animal body and which is of value in the treatment of diabetes mellitus . ( b ) The following substances , when they are intended for use in the manu ...
6. lappuse
... active ingredients over a prolonged period . There is a possibility of unsafe overdosage if such products are improperly made and the active ingredients are released at one time or over too short a time in- terval . Any such dosage form ...
... active ingredients over a prolonged period . There is a possibility of unsafe overdosage if such products are improperly made and the active ingredients are released at one time or over too short a time in- terval . Any such dosage form ...
8. lappuse
... active ingredient or if the product contains more than one active ingredient and a relevant strength can be associated with the product without indicating each active ingredient ( the established name and quantity of each active ...
... active ingredient or if the product contains more than one active ingredient and a relevant strength can be associated with the product without indicating each active ingredient ( the established name and quantity of each active ...
14. lappuse
... active in- gredients , if the label bears a proprie- tary name or designation for such mix- ture and there is no established name corresponding to such proprietary name or designation , the quantitative ingredient information required ...
... active in- gredients , if the label bears a proprie- tary name or designation for such mix- ture and there is no established name corresponding to such proprietary name or designation , the quantitative ingredient information required ...
18. lappuse
... active in- gredient in each drug unit or , when quantity does not accurately reflect drug potency , a statement of the drug potency . ( b ) Statements of weight of the con- tents shall in the case of prescription drugs be expressed in ...
... active in- gredient in each drug unit or , when quantity does not accurately reflect drug potency , a statement of the drug potency . ( b ) Statements of weight of the con- tents shall in the case of prescription drugs be expressed in ...
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
active ingredient adequate advertisement amended appropriate approved batch bear beling cation chapter chlorcyclizine clinical closures cluding Code contraindications control number Cosmetic Act cyclizine detoxification distribution distributor dosage form dose Drug Administration drug application Drug Enforcement Administration drug establishment drug listing drug prod drug product containers equipment established name evaluation exemption expiration date facture Federal Food Federal Register Food and Drug gram hexachlorophene intended licensed maintenance treatment manu manufac manufacturing meclizine medicated article(s medicated feed ment Methadone misbranded name or designation narcotic narcotic drugs National Office operations oral over-the-counter over-the-counter drug packaging and labeling packing paragraph patient patient's record pernicious anemia person potassium permanganate pregnancy Pregnancy category preparations prescription drugs principal display panel processing program physician proprietary name regulations safety sample shipment side effects specific storage submitted Subpart tained testing tients tion Title treatment program ture Type A medicated ucts
Populāri fragmenti
45. lappuse - Indications Based on a review of this drug by the National Academy of Sciences — National Research Council and/or other information, FDA has classified the indications as follows: Effective: For the management of the manifestations of psychotic disorders.
23. lappuse - There are. however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed...
24. lappuse - ProHance* should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
25. lappuse - Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Lortab 7.5/500 tablets, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
38. lappuse - Labeling on or within the package from which the drug is to be dispensed bears adequate information for its use, including indications, effects, dosages, routes, methods, and frequency and duration of administration, and any relevant hazards, contraindications, side effects, and precautions...
x. lappuse - All prices include regular domestic postage and handling and are subject to change. (Company or personal name) (Additional address/attention line) (Street address) 3.
53. lappuse - The same information concerning the ingredients of the drug as appears on the label and labeling on or within the package from which the drug is to be dispensed...
42. lappuse - REGULATIONS MAKING EXEMPTIONS SEC. 405. The Secretary shall promulgate regulations exempting from any labeling requirement of this Act (1) small open containers of fresh fruits and fresh vegetables and (2) food which is, in accordance with the practice of the trade, to be processed, labeled, or repacked in substantial quantities at establishments other than those where originally processed or packed, on condition that such food is not adulterated or misbranded under the provisions of this Act upon...
25. lappuse - Nursing Mothers: It is not known whether this drug is excreted in human milk Because many drugs are excreted in human milk, caution should be exercised when sucralfate is administered to a nursing woman...
16. lappuse - USP) 2.5. 5, and 10 mg contain FD&C Yellow No. 5 (tartrazine) which may cause allergic-type reactions (including bronchial asthma) in certain susceptible individuals. Although the overall incidence of FD&C Yellow No. 5 (tartrazine) sensitivity in the general population is low, it is frequently seen In patients who also have aspirin hypersensitivity.